BNGO vs XLI
Bionano Genomics Inc (BNGO) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.
XLI (XLI) common stock.
Latest reported BNGO revenue for 2026-06-30 was $14.9M. Net income was -$15.7M. BNGO currently screens at market cap $13.4M.
XLI does not have a complete income-statement cache yet.
BNGO currently screens at market cap $13.4M. XLI currently screens at market cap $0.
Not investment advice. Open the BNGO and XLI stock pages for the full models.
Not investment advice.